COVID-19 emergency responders in FDA's Center for Drug Evaluation and Research

J Am Pharm Assoc (2003). May-Jun 2020;60(3):527-528. doi: 10.1016/j.japh.2020.04.010. Epub 2020 Apr 9.
No abstract available

MeSH terms

  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Drug Development / organization & administration*
  • Emergency Responders*
  • Humans
  • Pandemics
  • Pharmacists / organization & administration*
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • Professional Role
  • United States
  • United States Food and Drug Administration
  • United States Public Health Service / organization & administration

Supplementary concepts

  • COVID-19